Prostate Cancer Negligence Claims

A PSA (Prostate-Specific Antigen) blood test is a key tool in assessing prostate health. If a test is not offered when it should have been, or if abnormal results are ignored or not followed up, opportunities for early diagnosis may be lost.

A PSA result should not usually be considered in isolation. In many claims, the pattern of results over time is important, including whether PSA levels were rising, whether repeat testing should have been arranged, and whether abnormal results should have led to referral for specialist urology assessment. If a raised PSA result was overlooked, not communicated properly, or not followed up within a reasonable period, this may have delayed diagnosis and treatment.

GPs and other frontline clinicians are expected to refer patients to a urologist or cancer specialist promptly when there are signs of prostate cancer. Any unnecessary delay in this referral process can result in the cancer progressing.

Referral delays may arise when symptoms are not recognised as potentially serious, when abnormal PSA results are not acted upon, or when a referral is made less urgently than the circumstances required. In prostate cancer claims, we will consider whether an earlier referral to a urologist or cancer specialist would probably have led to earlier diagnosis, different treatment options or a better long-term outcome.

MRI scans, CT scans, and prostate biopsies all require careful interpretation by trained specialists. Misreading results can lead to the wrong diagnosis or no diagnosis at all, delaying vital treatment.

These claims can be complicated because they often require expert evidence from radiologists, pathologists or urologists. We may need to consider whether scan findings were reported accurately, whether biopsy samples were interpreted correctly, and whether any abnormal result should have led to further testing or treatment. If the interpretation of results delayed diagnosis or led to inappropriate treatment, this may form part of a claim.

Sometimes the treatment offered is not suitable for the stage or type of cancer. Patients may undergo unnecessary surgery or radiotherapy, resulting in complications such as incontinence or sexual dysfunction.

When a patient is being monitored under an active surveillance plan, regular check-ups and tests are essential. Failures in this monitoring can lead to the cancer growing unchecked and becoming harder to treat.

Possibly. A PSA test is not used as a routine screening tool, but if you had symptoms such as urinary problems or were at higher risk due to your age, family history, or ethnic background, your GP should have considered it. If the opportunity to test was missed and your cancer was diagnosed later as a result, this could be classed as negligent care.

If your prostate cancer progressed because of a missed opportunity to diagnose or act earlier, you may be entitled to compensation. We will review your medical records and assess whether earlier action would have made a difference to your outcome.

Yes. If prostate cancer was diagnosed too late or not treated properly, and this contributed to your loved one’s death, you may be able to bring a claim. This could include compensation for financial losses, funeral costs, and the emotional impact on the family.

You usually have three years from the date you first realised something had gone wrong. This might be when you were diagnosed, or when you learned that your treatment could have been different. If you are claiming on behalf of someone who has died, the time limit is usually three years from the date of death.

If you were under regular care and warning signs were missed such as rising PSA levels or new symptoms not being investigated, this could point to negligent monitoring. We can review your medical history to see whether earlier action should have been taken.

Yes. Prostate cancer negligence claims are not limited to delayed diagnosis. Some claims involve treatment decisions that caused avoidable harm, such as unnecessary surgery, radiotherapy or hormone treatment. The question is whether the treatment was suitable for the type, stage and risk level of the cancer, and whether the patient was properly advised about reasonable alternatives and risks.

PSA test results can help show whether further investigation should have been considered. In some claims, the key issue is not a single result, but the pattern over time, including whether PSA levels were rising, whether repeat testing was needed, and whether an abnormal result should have led to referral for specialist urology assessment.

Potentially, yes. If abnormal PSA results, scan findings or biopsy results were not properly explained, you may have lost the opportunity to make informed decisions about further tests or treatment. These cases often depend on what information should reasonably have been given, what follow-up should have happened, and whether the lack of explanation caused avoidable harm.

A delayed diagnosis claim is usually investigated by reviewing the full medical timeline. This may include GP notes, symptoms reported, PSA test history, referral letters, urology records, scan reports, biopsy results and treatment plans. Independent medical experts may then be asked whether earlier testing, referral or treatment should have taken place, and whether this would probably have changed the outcome.